Brain Structure in Neuropsychologically Defined Subgroups of Schizophrenia and Psychotic Bipolar Disorder

Schizophrenia Bulletin

Volumn 41, Issue 6, 2015, Pages 1349-1359

  Woodward, Neil D ^a   Heckers, Stephan ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Brain volume; Cognition; Neurodev elopmental; Neuroprogressive; Psychosis

Indexed keywords

ADULT; ARTICLE; BIPOLAR DISORDER; BRAIN ATROPHY; BRAIN REGION; BRAIN SIZE; BRAIN TISSUE; COGNITIVE DEFECT; CONTROLLED STUDY; FEMALE; FRONTAL CORTEX; GRAY MATTER; HUMAN; HYPOPLASIA; INTELLECT; MAJOR CLINICAL STUDY; MALE; MENTAL PATIENT; NEUROANATOMY; NEUROPSYCHOLOGICAL TEST; NEUROPSYCHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; POSITIVE AND NEGATIVE SYNDROME SCALE; PRIORITY JOURNAL; PSYCHOSIS; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SUBCORTEX; TEMPORAL CORTEX; VOXEL BASED MORPHOMETRY; WHITE MATTER; ATROPHY; BRAIN; COGNITION DISORDERS; COMPLICATION; MIDDLE AGED; PATHOLOGY; YOUNG ADULT;

ADULT; ATROPHY; BIPOLAR DISORDER; BRAIN; COGNITION DISORDERS; FEMALE; GRAY MATTER; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PSYCHOTIC DISORDERS; SCHIZOPHRENIA; WHITE MATTER; YOUNG ADULT;

EID: 84946135748     PISSN: 05867614     EISSN: 17451701     Source Type: Journal    
DOI: 10.1093/schbul/sbv048     Document Type: Article

References (64)

1. Heinrichs RW, Zakzanis KK. Neurocognitive deficit in schizophrenia: a quantitative review of the evidence. Neuropsychology. 1998;12:426-445.
2. Dickinson D, Ragland JD, Gold JM, Gur RC. General and specific cognitive deficits in schizophrenia: Goliath defeats David? Biol Psychiatry. 2008;64:823-827.
3. Dickinson D, Ramsey ME, Gold JM. Overlooking the obvious: a meta-analytic comparison of digit symbol coding tasks and other cognitive measures in schizophrenia. Arch Gen Psychiatry. 2007;64:532-542.
4. Simonsen C, Sundet K, Vaskinn A, et al. Neurocognitive dysfunction in bipolar and schizophrenia spectrum disorders depends on history of psychosis rather than diagnostic group. Schizophr Bull. 2011;37:73-83.
5. Bora E, Yucel M, Pantelis C. Neurocognitive markers of psychosis in bipolar disorder: a meta-analytic study. J Affect Disord. 2010;127:1-9.
6. Palmer BW, Heaton RK, Paulsen JS, et al. Is it possible to be schizophrenic yet neuropsychologically normal? Neuropsychology. 1997;11:437-446.
7. Seaton BE, Allen DN, Goldstein G, Kelley ME, van Kammen DP. Relations between cognitive and symptom profile heterogeneity in schizophrenia. J Nerv Ment Dis. 1999;187:414-419.
8. Kremen WS, Seidman LJ, Faraone SV, Toomey R, Tsuang MT. The paradox of normal neuropsychological function in schizophrenia. J Abnorm Psychol. 2000;109:743-752.
9. Reichenberg A, Harvey PD, Bowie CR, et al. Neuropsychological function and dysfunction in schizophrenia and psychotic affective disorders. Schizophr Bull. 2009;35:1022-1029.
10. Martino DJ, Strejilevich SA, Scapola M, et al. Heterogeneity in cognitive functioning among patients with bipolar disorder. J Affect Disord. 2008;109:149-156.
11. McDaniel MA. Big-brained people are smarter: A metaanalysis of the relationship between in vivo brain volume and intelligence. Intelligence. 2005;33:337-346.
12. Rushton JP, Ankney CD. Whole brain size and general mental ability: a review. Int J Neurosci. 2009;119:691-731.
13. Glahn DC, Laird AR, Ellison-Wright I, et al. Meta-analysis of gray matter anomalies in schizophrenia: application of anatomic likelihood estimation and network analysis. Biol Psychiatry. 2008;64:774-781.
14. Cobia DJ, Csernansky JG, Wang L. Cortical thickness in neuropsychologically near-normal schizophrenia. Schizophr Res. 2011;133:68-76.
15. Allen DN, Seaton BE, Goldstein G, et al. Neuroanatomic differences among cognitive and symptom subtypes of schizophrenia. J Nerv Ment Dis. 2000;188:381-384.
16. Ortiz-Gil J, Pomarol-Clotet E, Salvador R, et al. Neural correlates of cognitive impairment in schizophrenia. Br J Psychiatry. 2011;199:202-210.
17. Wexler BE, Zhu H, Bell MD, et al. Neuropsychological near normality and brain structure abnormality in schizophrenia. Am J Psychiatry. 2009;166:189-195.
18. Weickert TW, Goldberg TE, Gold JM, Bigelow LB, Egan MF, Weinberger DR. Cognitive impairments in patients with schizophrenia displaying preserved and compromised intellect. Arch Gen Psychiatry. 2000;57:907-913.
19. Gilbert E, Merette C, Jomphe V, et al. Cluster analysis of cognitive deficits may mark heterogeneity in schizophrenia in terms of outcome and response to treatment. Eur Arch Psychiatry Clin Neurosci. 2013;264:333-343.
20. Joyce EM, Hutton SB, Mutsatsa SH, Barnes TR. Cognitive heterogeneity in first-episode schizophrenia. Br J Psychiatry. 2005;187:516-522.
21. Badcock JC, Dragovic M, Waters FA, Jablensky A. Dimensions of intelligence in schizophrenia: evidence from patients with preserved, deteriorated and compromised intellect. J Psychiatr Res. 2005;39:11-19.
22. Fiszdon JM, Choi J, Bryson GJ, Bell MD. Impact of intellectual status on response to cognitive task training in patients with schizophrenia. Schizophr Res. 2006;87:261-269.
23. Horan WP, Goldstein G. A retrospective study of premorbid ability and aging differences in cognitive clusters of schizophrenia. Psychiatry Res. 2003;118:209-221.
24. Kremen WS, Seidman LJ, Faraone SV, Tsuang MT. IQ decline in cross-sectional studies of schizophrenia: methodology and interpretation. Psychiatry Res. 2008;158:181-194.
25. Leeson VC, Sharma P, Harrison M, Ron MA, Barnes TR, Joyce EM. IQ trajectory, cognitive reserve, and clinical outcome following a first episode of psychosis: a 3-year longitudinal study. Schizophr Bull. 2011;37:768-777.
26. Kravariti E, Morgan K, Fearon P, et al. Neuropsychological functioning in first-episode schizophrenia. Br J Psychiatry. 2009;195:336-345.
27. Courchesne E, Chisum HJ, Townsend J, et al. Normal brain development and aging: quantitative analysis at in vivo MR imaging in healthy volunteers. Radiology. 2000;216:672-682.
28. Kamdar MR, Gomez RA, Ascherman JA. Intracranial volumes in a large series of healthy children. Plast Reconstr Surg. 2009;124:2072-2075.
29. Sgouros S, Goldin JH, Hockley AD, Wake MJ, Natarajan K. Intracranial volume change in childhood. J Neurosurg. 1999;91:610-616.
30. Lenroot RK, Gogtay N, Greenstein DK, et al. Sexual dimorphism of brain developmental trajectories during childhood and adolescence. Neuroimage. 2007;36:1065-1073.
31. Davis PJM, Wright EA. A new method for measuring cranial cavity volume and its applications to the assessment of cerebral atrophy at autopsy. Neuropathol Appl Neurobiol. 1977;3:341-358.
32. Roussotte FF, Sulik KK, Mattson SN, et al. Regional brain volume reductions relate to facial dysmorphology and neurocognitive function in fetal alcohol spectrum disorders. Hum Brain Mapp. 2012;33:920-937.
33. Glass RB, Fernbach SK, Norton KI, Choi PS, Naidich TP. The infant skull: a vault of information. Radiographics. 2004;24:507-522.
34. Bozzali M, Cercignani M, Caltagirone C. Brain volumetrics to investigate aging and the principal forms of degenerative cognitive decline: a brief review. Magn Reson Imaging. 2008;26:1065-1070.
35. Guo LH, Alexopoulos P, Wagenpfeil S, Kurz A, Perneczky R. Brain size and the compensation of Alzheimer's disease symptoms: a longitudinal cohort study. Alzheimers Dement. 2013;9:580-586.
36. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV Axis I Disorders, Clinical Version (SCID-CV). Washington, DC: American Psychiatric Press Inc; 1996.
37. Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13:261-276.
38. Wechsler D. Wechsler Test of Adult Reading. San Antonio, TX: Pearson Education; 2001.
39. Purdon SE. The Screen for Cognitive Impairment in Psychiatry (SCIP): Administration Manual and Normative Data. Alberta, Canada: PNL Inc; 2005.
40. Pino O, Guilera G, Rojo JE, et al. Spanish version of the Screen for Cognitive Impairment in Psychiatry (SCIP-S): psychometric properties of a brief scale for cognitive evaluation in schizophrenia. Schizophr Res. 2008;99:139-148.
41. Guilera G, Pino O, Gomez-Benito J, et al. Clinical usefulness of the screen for cognitive impairment in psychiatry (SCIP-S) scale in patients with type I bipolar disorder. Health Qual Life Outcomes. 2009;7:28.
42. Rojo E, Pino O, Guilera G, et al. Neurocognitive diagnosis and cut-off scores of the Screen for Cognitive Impairment in Psychiatry (SCIP-S). Schizophr Res. 2010;116:243-251.
43. Cuesta MJ, Pino O, Guilera G, et al. Brief cognitive assessment instruments in schizophrenia and bipolar patients, and healthy control subjects: a comparison study between the Brief Cognitive Assessment Tool for Schizophrenia (B-CATS) and the Screen for Cognitive Impairment in Psychiatry (SCIP). Schizophr Res. 2011;130:137-142.
44. Hurford IM, Marder SR, Keefe RS, Reise SP, Bilder RM. A brief cognitive assessment tool for schizophrenia: construction of a tool for clinicians. Schizophr Bull. 2011;37:538-545.
45. Lezak MD. Neuropsychological Assessment. 3rd ed. New York, NY: Oxford University Press; 1995.
46. Reitan RM. Relationships between measures of brain functions and general intelligence. J Clin Psychol. 1985;41:245-253.
47. Wechsler D. Wechsler Adult Intelligence Scale-3rd Edition. 3rd ed. San Antonio, TX: The Psychological Corporation; 1997.
48. Ashburner J. A fast diffeomorphic image registration algorithm. Neuroimage. 2007;38:95-113.
49. Gardner DM, Murphy AL, O'Donnell H, Centorrino F, Baldessarini RJ. International consensus study of antipsychotic dosing. Am J Psychiatry. 2010;167:686-693.
50. Wilk CM, Gold JM, McMahon RP, Humber K, Iannone VN, Buchanan RW. No, it is not possible to be schizophrenic yet neuropsychologically normal. Neuropsychology. 2005;19:778-786.
51. Kahn RS, Keefe RS. Schizophrenia is a cognitive illness: time for a change in focus. JAMA Psychiatry. 2013;70:1107-1112.
52. Heckers S. What is the core of schizophrenia? JAMA Psychiatry. 2013;70:1009-1010.
53. Goldberg TE, Ragland JD, Torrey EF, Gold JM, Bigelow LB, Weinberger DR. Neuropsychological assessment of monozygotic twins discordant for schizophrenia. Arch Gen Psychiatry. 1990;47:1066-1072.
54. Keefe RS, Eesley CE, Poe MP. Defining a cognitive function decrement in schizophrenia. Biol Psychiatry. 2005;57:688-691.
55. Khandaker GM, Zimbron J, Lewis G, Jones PB. Prenatal maternal infection, neurodevelopment and adult schizophrenia: a systematic review of population-based studies. Psychol Med. 2013;43:239-257.
56. Meier MH, Caspi A, Reichenberg A, et al. Neuropsychological decline in schizophrenia from the premorbid to the postonset period: evidence from a population-representative longitudinal study. Am J Psychiatry. 2014;171:91-101.
57. Ho BC, Andreasen NC, Ziebell S, Pierson R, Magnotta V. Long-term antipsychotic treatment and brain volumes: a longitudinal study of first-episode schizophrenia. Arch Gen Psychiatry. 2011;68:128-137.
58. Dykiert D, Deary IJ. Retrospective validation of WTAR and NART scores as estimators of prior cognitive ability using the Lothian Birth Cohort 1936. Psychol Assess. 2013;25:1361-1366.
59. Mesholam-Gately RI, Giuliano AJ, Goff KP, Faraone SV, Seidman LJ. Neurocognition in first-episode schizophrenia: a meta-analytic review. Neuropsychology. 2009;23:315-336.
60. Woodberry KA, Giuliano AJ, Seidman LJ. Premorbid IQ in schizophrenia: a meta-analytic review. Am J Psychiatry. 2008;165:579-587.
61. Gur RC, Calkins ME, Satterthwaite TD, et al. Neurocognitive growth charting in psychosis spectrum youths. JAMA Psychiatry. 2014;71:366-374.
62. Seidman LJ, Buka SL, Goldstein JM, Tsuang MT. Intellectual decline in schizophrenia: evidence from a prospective birth cohort 28 year follow-up study. J Clin Exp Neuropsychol. 2006;28:225-242.
63. Reichenberg A, Weiser M, Rapp MA, et al. Elaboration on premorbid intellectual performance in schizophrenia: premorbid intellectual decline and risk for schizophrenia. Arch Gen Psychiatry. 2005;62:1297-1304.
64. Bilder RM, Reiter G, Bates J, et al. Cognitive development in schizophrenia: follow-back from the first episode. J Clin Exp Neuropsychol. 2006;28:270-282.